Haoxi Health Technology Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on December 10, 2025, reports on an Extraordinary General Meeting (EGM) of shareholders held on December 8, 2025, in Beijing, China. The filing details the approval of significant corporate governance changes, including voting power adjustments, share capital increases, and a potential share consolidation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate actions and shareholder voting results rather than financial performance.
Material Changes and Corporate Actions
Shareholders approved six key resolutions at the EGM:
- Change of Voting Power: Voting rights for Class B ordinary shares were increased from 10 votes per share to 30 votes per share.
- Pre-Consolidation Capital Increase: Authorized share capital increased from USD 1,000,000 to USD 3,250,000, creating 900,000,000 new Class A ordinary shares.
- Share Consolidation Authorization: The Board was authorized to consolidate Class A and Class B shares at a ratio between 2:1 and 150:1, effective any time prior to November 15, 2026. The exact ratio and date are at the Board's discretion.
- Post-Consolidation Capital Increase: Conditional on the consolidation, authorized share capital may be increased to a maximum of USD 450,250,000.
- Amendments to Charter: The Memorandum and Articles of Association were amended and restated (Sixth M&A and Further Amendment) to reflect these changes.
Voting Results
A quorum was present with 5,760,234 Class A shares and 690,800 Class B shares represented. All resolutions passed with overwhelming support:
| Resolution | For | Against | Abstain |
|---|---|---|---|
| Change of Voting Power | 12,602,421 | 65,813 | 0 |
| Pre-Consolidation Capital Increase | 12,602,404 | 65,830 | 0 |
| Amendment to Fifth M&A | 12,602,431 | 65,803 | 0 |
| Share Consolidation | 12,602,468 | 65,761 | 5 |
| Post-Consolidation Capital Increase | 12,602,363 | 65,871 | 0 |
| Further Amendment to M&A | 12,602,361 | 65,826 | 47 |
Outlook and Risks
The Board retains sole discretion to determine the specific consolidation ratio (between 2:1 and 150:1) and the effective date, provided it occurs before November 15, 2026. The Board may also elect not to implement the consolidation. No specific financial guidance or operational risks were disclosed in this filing.
Investor Verification Checklist
- Verify the exact share consolidation ratio and effective date once announced by the Board.
- Confirm the impact of the 30-vote Class B share structure on future control dynamics.
- Monitor for the issuance of the new Class A shares authorized under the pre-consolidation increase.
- Review the Sixth Amended and Restated Memorandum and Articles of Association for detailed governance terms.